Targeting DNA repair for precision radiotherapy: Balancing the therapeutic ratio

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Genomic instability, driven by DNA damage response and repair pathway defects, contributes to tumor progression and aggression.
• Tumor cell sensitivity to therapies like chemotherapy and radiotherapy is influenced by their DNA repair capacity.
• Understanding these pathways is crucial for advancing cancer treatment strategies.

Purpose of the Study:

• To explore the potential of annotating DNA damage response and repair defects for novel prognostic biomarkers.
• To investigate the utility of this information in predicting therapeutic responses, particularly in precision radiotherapy.
• To highlight the growing importance of targeting DNA repair deficiencies in cancer care.

Main Methods:

• Review of current literature on DNA damage response and repair pathways in cancer.
• Analysis of the relationship between genomic instability and tumor phenotypes.
• Exploration of methods for annotating functional defects in DNA repair mechanisms.

Main Results:

• Functional defects in DNA repair pathways are linked to genomic instability and tumor aggression.
• Tumor cell DNA repair capacity significantly impacts sensitivity to radiotherapy and chemotherapy.
• Annotation of these defects shows potential for developing new prognostic and predictive biomarkers.

Conclusions:

• Annotating DNA repair defects can identify patients likely to benefit from specific therapies.
• Targeting DNA repair pathways represents a key strategy in precision oncology.
• This approach holds promise for improving outcomes in patients undergoing precision radiotherapy.